cholecystokinin

Preferred Label : cholecystokinin;

MeSH definition : A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.;

MeSH synonym : uropancreozymin; pancreozymin;

MeSH hyponym : CCK-33; Cholecystokinin 33;

Registry Number MeSH : 9011-97-6;

Wikipedia link : https://en.wikipedia.org/wiki/Cholecystokinin;

Is substance : O;

Details

Origin ID

D002766;

UMLS CUI

C0008328;

ATC code(s)
- pancreozymin (cholecystokinin) [ATC Code]
ATC code(s)
- pancreozymin (cholecystokinin) [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Cholecystokinin [NCIt concept]
- Cholecystokinin [ICD-11 Extension code]
- Cholecystokinin [LOINC part]
- Cholecystokinin [ICHI extension code]
- Cholecystokinin [FMA entity]
- Cholecystokinin [LOINC component]
- Cholecystokinin (substance) [SNOMED CT concept]
- cholecystokinin [SNOMED Notion]
- cholecystokinin [Artificial nutrition thesaurus concept]
- cholecystokinin [Radlex concept]
Indexing information
- 2,7-dioxo-2,3,4,5,6,7-hexahydro-1H-benzo(h)(1,4)diazonine [MeSH Supplementary Concept]
- RB 360 [MeSH Supplementary Concept]
Pharmacological action(s)
- cholagogues and choleretics [MeSH Descriptor]
Record concept(s)
- CCK-33 [MeSH concept]
- cholecystokinin [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-(biotin-epsilon-(aminohexanoyl)oxymethyl)-3-nitrobenzoyl-glycyl-(propionyl)ornithinyl-epsilon-aminohexanoyl-cholecystokinin [MeSH Supplementary Concept]
- 4-alanyloxymethyl-3-nitrobenzoyl-epsilon-aminohexanoyl-cholecystokinin [MeSH Supplementary Concept]
- A 68552 [MeSH Supplementary Concept]
- ARL 15849XX [MeSH Supplementary Concept]
- BC 197 [MeSH Supplementary Concept]
- BC 264 [MeSH Supplementary Concept]
- CCK 15 [MeSH Supplementary Concept]
- JMV 176 [MeSH Supplementary Concept]
- MP 2286 [MeSH Supplementary Concept]
- MP 2288 [MeSH Supplementary Concept]
- SNF 8815 [MeSH Supplementary Concept]
- SNF 9007 [MeSH Supplementary Concept]
- U 67827E [MeSH Supplementary Concept]
- V-9-M cholecystokinin nonapeptide [MeSH Supplementary Concept]
- benzyloxycarbonyl-glycyl-tryptophyl-methionyl-aspartyl(OBu-t)-phenylalaninamide [MeSH Supplementary Concept]
- butyloxycarbonyl-tryptophyl-leucyl-aspartyl-phenylalaninamide [MeSH Supplementary Concept]
- cholecystokinin (1-14) [MeSH Supplementary Concept]
- cholecystokinin (10-20) [MeSH Supplementary Concept]
- cholecystokinin (25-33), Thr(28)-Nle(31)- [MeSH Supplementary Concept]
- cholecystokinin (25-33), Tyr(25)-Nle(28,31)- [MeSH Supplementary Concept]
- cholecystokinin (25-33), biotinyl-Tyr-Gly-(Thr(28)-Nle(31))- [MeSH Supplementary Concept]
- cholecystokinin (25-33),2-(4-azidosalicylamido)-1,3-dithiopropionate(Thr(28)-AHX(31))- [MeSH Supplementary Concept]
- cholecystokinin (26-32) phenylethyl ester, tyrosyl-glycyl-(norleucyl(28.31)-tryptophyl(30))- [MeSH Supplementary Concept]
- cholecystokinin (26-33), indium-DOTA(0)-Asp(26)-Nle(28,31)- [MeSH Supplementary Concept]
- cholecystokinin (26-33), iodo-Tyr-Gly--Nle(28,31)-Bpa(33)- [MeSH Supplementary Concept]
- cholecystokinin (26-33), iodo-Tyr-Gly-Nle(28,31)-Bpa(29-33)- [MeSH Supplementary Concept]
- cholecystokinin (27-32) amide, benzoyloxycarbonyl- [MeSH Supplementary Concept]
- cholecystokinin (27-32)-amide [MeSH Supplementary Concept]
- cholecystokinin (29-33)-amide [MeSH Supplementary Concept]
- cholecystokinin (31-33) amide, butyloxycarbonyl- [MeSH Supplementary Concept]
- cholecystokinin (31-39), Thr(34)-Ahx(37)- [MeSH Supplementary Concept]
- cholecystokinin 10 C-terminal fragment [MeSH Supplementary Concept]
- cholecystokinin 12 C-terminal fragment [MeSH Supplementary Concept]
- cholecystokinin 21 [MeSH Supplementary Concept]
- cholecystokinin 22 C-terminal fragment [MeSH Supplementary Concept]
- cholecystokinin 33 (10-20) [MeSH Supplementary Concept]
- cholecystokinin 39 [MeSH Supplementary Concept]
- cholecystokinin 5-pentagastrin [MeSH Supplementary Concept]
- cholecystokinin 58 [MeSH Supplementary Concept]
- cholecystokinin 8 [MeSH Supplementary Concept]
- cholecystokinin 9 [MeSH Supplementary Concept]
- cholecystokinin C-terminal flanking peptide [MeSH Supplementary Concept]
- cholecystokinin precursor C-terminal pentapeptide [MeSH Supplementary Concept]
- cholecystokinin, gly- [MeSH Supplementary Concept]
- cholecystokinin-J [MeSH Supplementary Concept]
- desulfated benzyloxycarbonyl cholecystokinin (26-33) [MeSH Supplementary Concept]
- dimyristoylmercaptoglycero-N(alpha)maleoyl-beta-alanyl(Thr,Nle)-CCK-9 [MeSH Supplementary Concept]
- pBC 264 [MeSH Supplementary Concept]
- preprocholecystokinin [MeSH Supplementary Concept]
- procholecystokinin [MeSH Supplementary Concept]
- ro 23-7014 [MeSH Supplementary Concept]
- sulfated cholecystokinin 15 [MeSH Supplementary Concept]
- t-butyloxycarbonyl-sulfotyrosyl-norleucyl-glycyl-tyrosyl-aspartyl-2-phenylethyl ester [MeSH Supplementary Concept]
See also
- gastrointestinal agents [MeSH Descriptor]
- receptors, cholecystokinin [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cholecystokinin [LOINC part]
- Cholecystokinin [FMA entity]
- Cholecystokinin [LOINC component]
- Cholecystokinin (substance) [SNOMED CT concept]
- Product containing cholecystokinin (medicinal product) [SNOMED CT concept]
- cholecystokinin [SNOMED Notion]
- cholecystokinin preparation [SNOMED Notion]
- pancreozymin (cholecystokinin) [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients